Long CA - Search Results

1

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.

Duncan CJ, Sheehy SH, Ewer KJ, Douglas AD, Collins KA, Halstead FD, Elias SC, Lillie PJ, Rausch K, Aebig J, Miura K, Edwards NJ, Poulton ID, Hunt-Cooke A, Porter DW, Thompson FM, Rowland R, Draper SJ, Gilbert SC, Fay MP, Long CA, Zhu D, Wu Y, Martin LB, Anderson CF, Lawrie AM, Hill AV, Ellis RD. Duncan CJ, et al. Among authors: long ca. PLoS One. 2011;6(7):e22271. doi: 10.1371/journal.pone.0022271. Epub 2011 Jul 22. PLoS One. 2011. PMID: 21799809 Free PMC article. Clinical Trial.

2

Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations.

Miles AP, McClellan HA, Rausch KM, Zhu D, Whitmore MD, Singh S, Martin LB, Wu Y, Giersing BK, Stowers AW, Long CA, Saul A. Miles AP, et al. Among authors: long ca. Vaccine. 2005 Mar 31;23(19):2530-9. doi: 10.1016/j.vaccine.2004.08.049. Vaccine. 2005. PMID: 15752840

3

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, Long CA, Lambert L, Miles AP, Wang J, Stowers A, Miller LH, Saul A. Malkin EM, et al. Among authors: long ca. Vaccine. 2005 May 2;23(24):3131-8. doi: 10.1016/j.vaccine.2004.12.019. Vaccine. 2005. PMID: 15837212 Free PMC article. Clinical Trial.

4

posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.

Giersing B, Miura K, Shimp R, Wang J, Zhou H, Orcutt A, Stowers A, Saul A, Miller LH, Long C, Singh S. Giersing B, et al. Infect Immun. 2005 Jul;73(7):3963-70. doi: 10.1128/IAI.73.7.3963-3970.2005. Infect Immun. 2005. PMID: 15972483 Free PMC article.

5

Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide.

Mullen GE, Giersing BK, Ajose-Popoola O, Davis HL, Kothe C, Zhou H, Aebig J, Dobrescu G, Saul A, Long CA. Mullen GE, et al. Among authors: long ca. Vaccine. 2006 Mar 24;24(14):2497-505. doi: 10.1016/j.vaccine.2005.12.034. Epub 2006 Jan 4. Vaccine. 2006. PMID: 16434128

6

Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.

Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA. Singh S, et al. Among authors: long ca. Infect Immun. 2006 Aug;74(8):4573-80. doi: 10.1128/IAI.01679-05. Infect Immun. 2006. PMID: 16861644 Free PMC article.

7

Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria.

Malkin E, Long CA, Stowers AW, Zou L, Singh S, MacDonald NJ, Narum DL, Miles AP, Orcutt AC, Muratova O, Moretz SE, Zhou H, Diouf A, Fay M, Tierney E, Leese P, Mahanty S, Miller LH, Saul A, Martin LB. Malkin E, et al. Among authors: long ca. PLoS Clin Trials. 2007;2(4):e12. doi: 10.1371/journal.pctr.0020012. Epub 2007 Apr 6. PLoS Clin Trials. 2007. PMID: 17415408 Free PMC article.

8

Formulation of vaccines containing CpG oligonucleotides and alum.

Aebig JA, Mullen GE, Dobrescu G, Rausch K, Lambert L, Ajose-Popoola O, Long CA, Saul A, Miles AP. Aebig JA, et al. Among authors: long ca. J Immunol Methods. 2007 Jun 30;323(2):139-46. doi: 10.1016/j.jim.2007.04.003. Epub 2007 May 11. J Immunol Methods. 2007. PMID: 17512533 Free PMC article.

9

Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen.

Mullen GE, Aebig JA, Dobrescu G, Rausch K, Lambert L, Long CA, Miles AP, Saul A. Mullen GE, et al. Among authors: long ca. Vaccine. 2007 Jul 20;25(29):5343-7. doi: 10.1016/j.vaccine.2007.05.007. Epub 2007 May 25. Vaccine. 2007. PMID: 17566616 Free PMC article.

10

Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.

Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A. Miura K, et al. Among authors: long ca. Malar J. 2007 Aug 8;6:107. doi: 10.1186/1475-2875-6-107. Malar J. 2007. PMID: 17686163 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

361 results

Search Page